Applicant, as named in the Orange Book

Amicus Therap Us

Next listed expiry: Opfolda on 16 Sep 2038. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Opfolda miglustat	miglustat	215211	16 Sep 2038	patent, carve-out possible
Galafold migalastat hydrochloride	migalastat hydrochloride	208623	11 Jan 2042	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.